INDICATOR EXPRESSION DIRECTED BY REGULATORY SEQUENCES OF THE GLIAL FIBRILLARY ACIDIC PROTEIN (GFAP) GENE - IN-VIVO COMPARISON OF DISTINCT GFAP-LACZ TRANSGENES
Wb. Johnson et al., INDICATOR EXPRESSION DIRECTED BY REGULATORY SEQUENCES OF THE GLIAL FIBRILLARY ACIDIC PROTEIN (GFAP) GENE - IN-VIVO COMPARISON OF DISTINCT GFAP-LACZ TRANSGENES, Glia, 13(3), 1995, pp. 174-184
An increase in the expression of the glial fibrillary acidic protein (
GFAP) gene by astrocytes appears to constitute a crucial component of
the brain's response to injury because it is seen in many different sp
ecies and features prominently in diverse neurological diseases. Previ
ously, we have used a modified GFAP gene (C-339) to target the express
ion of beta-galactosidase (beta-gal) to astrocytes in transgenic mice
(Mucke et al.; New Biol 3:465-474 1991). To determine to what extent t
he in vivo(1) expression of GFAP-driven fusion genes is influenced by
intragenic GFAP sequences, the E. coli lacZ reporter gene was either p
laced downstream of approximately 2 kb of murine GFAP 5' flanking regi
on (C-259) or ligated into exon 1 of the entire murine GFAP gene (C-44
5). Transgenic mice expressing C-259 versus C-445 showed similar level
s and distributions of beta-gal activity in their brains. Exclusion of
intragenic GFAP sequences from the GFAP-lacZ fusion gene did not dimi
nish injury-induced upmodulation of astroglial beta-gal expression or
increase beta-gal expression in non-astrocytic brain cells. These resu
lts demonstrate that 2 kb of murine GFAP 5' flanking region is suffici
ent to restrict transgene expression primarily to astrocytes and to me
diate injury-responsiveness in vivo. This sequence therefore constitut
es a critical target for mediators of reactive astrocytosis. While acu
te penetrating brain injuries induced focal increases in beta-gal expr
ession around the lesion sites in C-259, C-445, and C-339 transgenic m
ice, infection of C-339 transgenic mice with scrapie led to a widespre
ad upmodulation of astroglial beta-gal expression. Hence, GFAP-lacZ tr
ansgenic mice can be used to monitor differential patterns of astrogli
al activation in vivo. These and related models should facilitate the
assessment of strategies aimed at the in vive manipulation of GFAP exp
ression and astroglial activation. (C) 1995 Wiley-Liss, Inc.